David Owens - Jun 10, 2024 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Role
Chief Medical Officer, Director
Signature
/s/ David Owens, Name: David Owens, M.D.
Stock symbol
NXL
Transactions as of
Jun 10, 2024
Transactions value $
$1,920
Form type
4
Date filed
6/12/2024, 01:19 PM
Previous filing
Sep 20, 2022
Next filing
Jun 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXL Common stock Purchase $1.3K +2K +1.42% $0.65 143K Jun 10, 2024 Direct
transaction NXL Common stock Purchase $620 +1K +0.7% $0.62 144K Jun 10, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.